Home›Companies›Inceptive Nucleics

Inceptive Nucleics, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 20, 2023·Suggest an edit

About Inceptive Nucleics

Inceptive Nucleics is a private company based in Palo Alto, California, incorporated in 2021 in Delaware. It has reported $99,699,966 raised in one offering on Form D since September 2023. Its chief executive is Jakob Uszkoreit.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 6, 2023Sep 20, 2023$99,699,966of $99.9M target8$12.4MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Inceptive Nucleics's Form D filed Sep 20, 2023.

JU
Jakob Uszkoreit
Chief Executive Officer and director
KH
Kevin Heyries
Executive officer
VP
Vijay Pande
Director
DA
Diana Ajuria
Executive officer
DK
Do Soon Kim
Executive officer

Sources

  1. SECInceptive Nucleics, Inc. filing history